Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

2.29USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$2.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
54,326
52-wk High
$15.90
52-wk Low
$2.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -1.651
Jun '18 0.00 -1.687
Mar '18 0.00 -2.068
FY 2017 Dec '17 0.00 -3.220
Sep '17 0.00 -2.576
Jun '17 0.00 -2.319
Mar '17 0.00 -2.407
FY 2016 Dec '16 0.00 -3.436
Sep '16 0.00 -4.260
Jun '16 0.00 -4.928
Mar '16 0.00 9.097
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 1 -0.87 -0.87 -0.87 -2.50
Quarter Ending Mar-19 1 -0.88 -0.88 -0.88 --
Year Ending Dec-18 1 -3.59 -3.59 -3.59 -9.60
Year Ending Dec-19 1 -3.03 -3.03 -3.03 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.86 33.64
P/E High - Last 5 Yrs. -- 40.52 45.61
P/E Low - Last 5 Yrs. -- 23.24 23.70
Beta 1.02 0.89 0.88
Price to Sales (TTM) -- 4.02 5.95
Price to Book (MRQ) 2.13 4.77 4.89
Price to Tangible Book (MRQ) 2.60 5.60 6.50
Price to Cash Flow (TTM) -- 22.52 22.90
% Owned Institutions 7.03 1.13 2.15

Dividends

  Company industry sector
Dividend Yield -- 1.59 1.51
Dividend Yield - 5 Year Avg -- 1.59 1.52
Dividend 5 Year Growth Rate -- 4.42 5.41
Payout Ratio(TTM) -- 46.15 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.23 8.08
Sales (TTM) vs TTM 1 Yr. Ago -- 4.64 5.80
Sales - 5 Yr. Growth Rate -- 9.65 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 52.94 19.34 23.27
EPS (TTM) vs TTM 1 Yr. Ago -33.17 -- --
EPS - 5 Yr. Growth Rate -- 9.95 10.88
Capital Spending - 5 Yr. Growth Rate -9.41 15.07 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.27
Current Ratio (MRQ) 5.88 2.99 3.07
LT Debt to Equity (MRQ) 0.03 10.29 13.15
Total Debt to Equity (MRQ) 0.06 14.52 17.74
Interest Coverage (TTM) -- 41.32 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.21 54.86
Gross Margin - 5 Yr. Avg. -- 52.32 52.38
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.47 10.90
Operating Margin (TTM) -- 14.21 3.24
Operating Margin - 5 Yr. Avg. -- 14.35 6.22
Pre-Tax Margin (TTM) -- 14.75 4.31
Pre-Tax Margin - 5 Yr. Avg. -- 14.80 6.66
Net Profit Margin (TTM) -- 10.97 0.58
Net Profit Margin - 5 Yr. Avg. -- 11.07 2.90
Effective Tax Rate (TTM) -- 23.35 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.63 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 905,167,346 803,310,395
Net Income/Employee (TTM) -725,656 106,519,628 94,478,415
Receivable Turnover (TTM) -- 5.61 5.78
Inventory Turnover (TTM) -- 2.61 3.71
Asset Turnover (TTM) 0.00 0.94 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -90.79 11.33 10.86
Return on Assets - 5 Yr. Avg. -75.22 12.57 11.96
Return on Investment (TTM) -103.68 14.72 14.22
Return on Investment - 5 Yr. Avg. -115.63 16.38 15.54
Return on Equity (TTM) -105.20 16.27 15.99
Return on Equity - 5 Yr. Avg. -127.41 17.46 16.82
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 80.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.24%
# of Holders: 18
Total Shares Held: 122,884
3 Mo. Net Change: 32,764
# New Positions: 4
# Closed Positions: 7
# Increased Positions: 5
# Reduced Positions: 9
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.